Related Experiment Video
Updated: May 3, 2026
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Cholesterol, lipoproteins, high-sensitivity c-reactive protein, and other risk factors for atherosclerosis
Joseph Rudolf1, Kent B Lewandrowski1
1Division of Laboratory Medicine, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114-2696, USA.
Insights
Coronary heart disease (CHD) risk assessment is evolving beyond traditional factors. Emerging biological and genetic markers are improving CHD understanding and patient stratification.
Area of Science:
- Cardiology
- Preventive Medicine
- Biomarkers
Background:
- Coronary heart disease (CHD) represents a significant public health burden in Western societies.
- Traditional CHD risk assessment relies on established factors like age, hypertension, cholesterol, family history, and smoking.
- Advances in understanding CHD pathogenesis necessitate updated risk stratification strategies.
Purpose of the Study:
- To explore the impact of emerging risk factors on coronary heart disease assessment.
- To highlight the evolving landscape of CHD risk stratification.
- To discuss the growing importance of novel biomarkers in clinical practice.
Main Methods:
- Review of current literature on coronary heart disease risk factors.
- Analysis of traditional versus emerging risk stratification parameters.
- Discussion of the clinical integration of new biological and genetic assays.
Main Results:
- Traditional risk factors provide a foundational but incomplete picture of CHD risk.
- Emerging biological and genetic factors offer deeper insights into individual CHD susceptibility.
- Standardization and automation of new assays are increasing their clinical utility.
Conclusions:
- The understanding of coronary heart disease pathogenesis is advancing rapidly.
- Emerging risk factors are crucial for refining CHD risk stratification.
- Novel biomarkers are becoming indispensable tools for CHD assessment and management.
Abstract:
Coronary heart disease is a common and costly epidemic in the Western world. Intensive study has led to a deeper understanding of the pathogenesis of coronary disease and risk stratification. Traditional risk factor assessment has focused on parameters derived from the Framingham Heart Study (age, hypertension, cholesterol, family history, and cigarette smoking). New emerging risk factors, both biological and genetic, are reshaping the understanding of heart disease and the approach to risk stratification. As these emerging assays become more standardized, automated, and inexpensive to perform, they are becoming increasingly important tools in the assessment and treatment of coronary heart disease.
Related Concept Videos
01:30Atherosclerosis I: Introduction
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Coronary Artery Disease I: Introduction
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests